TUMOR NECROSIS PREDICTS SURVIVAL FOLLOWING NEO-ADJUVANT CHEMOTHERAPY FOR HEPATOBLASTOMA

被引：0
|
作者：
Venkatramani, Rajkumar [1 ]
Wang, Larry [1 ]
Malvar, Jemily [1 ]
Sposto, Richard [1 ]
Malogolowkin, Marcio [1 ]
Mascarenhas, Leo [1 ]
机构：
[1] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA
来源：
PEDIATRIC BLOOD & CANCER | 2011年 / 56卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：901 / 901
页数：1
相关论文
共 50 条
  • [41] Selection of patients with oesophageal cancer for neo-adjuvant chemotherapy
    O'Donohoe, L
    Morrison, JJ
    Graham, L
    Deans, C
    de Beaux, AC
    Paterson-Brown, S
    BRITISH JOURNAL OF SURGERY, 2003, 90 : 126 - 127
  • [42] Prognostic value of restaging CT for operable gastroesophageal carcinoma following neo-adjuvant chemotherapy
    Daskalakis, Markos
    Dickenson, Edward
    Richardson, Martin
    Nijjar, Rajwinder
    BRITISH JOURNAL OF SURGERY, 2013, 100 : 47 - 47
  • [43] A DNA-damage immune response assay combined with PET biomarkers predicts response to neo-adjuvant chemotherapy and survival in oesophageal adenocarcinoma
    Foley, Kieran G.
    Lavery, Anita
    Napier, Eoin
    Campbell, David
    Eatock, Martin M.
    Kennedy, Richard D.
    Bradley, Kevin M.
    Turkington, Richard C.
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [44] Tumour regression grading correlates to survival in oesophago-gastric cancer. A report of current survival outcomes following neo-adjuvant chemotherapy
    Reece-Smith, A. M.
    Soomro, I.
    Madhusudan, S.
    Parsons, S. L.
    BRITISH JOURNAL OF SURGERY, 2012, 99 : 22 - 22
  • [45] A DNA-damage immune response assay combined with PET biomarkers predicts response to neo-adjuvant chemotherapy and survival in oesophageal adenocarcinoma
    Kieran G. Foley
    Anita Lavery
    Eoin Napier
    David Campbell
    Martin M. Eatock
    Richard D. Kennedy
    Kevin M. Bradley
    Richard C. Turkington
    Scientific Reports, 11
  • [46] TUMOUR REGRESSION GRADING CORRELATES TO SURVIVAL IN OESOPHAGO-GASTRIC CANCER. A REPORT OF CURRENT SURVIVAL OUTCOMES FOLLOWING NEO-ADJUVANT CHEMOTHERAPY
    Reece-Smith, A. M.
    Soomro, I.
    Madhusudan, S.
    Parsons, S. L.
    GUT, 2012, 61 : A45 - A45
  • [47] Non-small cell lung cancer: Adjuvant and neo-adjuvant chemotherapy
    Brahmer, Julie R.
    Ettinger, David S.
    RESPIROLOGY, 2007, 12 (03) : 320 - 325
  • [48] A review of the current evidence for the role of minimally invasive pancreatic surgery following neo-adjuvant chemotherapy
    Robertson, Francis P.
    Parks, Rowan W.
    LAPAROSCOPIC ENDOSCOPIC AND ROBOTIC SURGERY, 2022, 5 (02): : 47 - 51
  • [49] Prognostic impact of neo-adjuvant vs adjuvant vs neo-adjuvant plus adjuvant chemotherapy in advanced ovarian cancer: Analysis of National Cancer Database.
    Mukkamala, Suresh
    Saha, Sukamal
    Ramanathan, Sabarina
    Livert, David
    Oza, Rajen
    Salib, Hayman S.
    Bajaj, Vinay
    Lee, Jeen
    Wiese, David
    Arora, Madan L.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [50] On prediction of response to neo-adjuvant chemotherapy for primary oesophageal adenocarcinoma
    Saha, A.
    Rotimi, O.
    Sarela, A.
    Sue-Ling, H.
    Hardie, L.
    BRITISH JOURNAL OF SURGERY, 2012, 99 : 105 - 105
12345